Skip to main content

Peer Review reports

From: Efficacy and safety of HER2 inhibitors in combination with or without pertuzumab for HER2-positive breast cancer: a systematic review and meta-analysis

Original Submission
21 May 2019 Submitted Original manuscript
10 Jun 2019 Reviewed Reviewer Report - Wen-Wei Chang
17 Jun 2019 Reviewed Reviewer Report - Robert Wesolowski
19 Jul 2019 Author responded Author comments - Shanshan Chen
Resubmission - Version 2
19 Jul 2019 Submitted Manuscript version 2
19 Jul 2019 Reviewed Reviewer Report - Wen-Wei Chang
18 Aug 2019 Reviewed Reviewer Report - Robert Wesolowski
22 Aug 2019 Author responded Author comments - Shanshan Chen
Resubmission - Version 3
22 Aug 2019 Submitted Manuscript version 3
29 Aug 2019 Author responded Author comments - Shanshan Chen
Resubmission - Version 4
29 Aug 2019 Submitted Manuscript version 4
Publishing
3 Sep 2019 Editorially accepted
21 Oct 2019 Article published 10.1186/s12885-019-6132-0

You can find further information about peer review here.

Back to article page